Clinical Trial Categories
ITP Trials
O-FOSTA-901
Avavilable at 12 locations
Observational Study of Fostamatinib as Second Line Therapy in Adult Patients with Immune Thrombocytopenia (ITP) and Insufficient Response to a Prior Therapy
